381 related articles for article (PubMed ID: 17064254)
1. Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites.
Holleran BJ; Beaulieu ME; Proulx CD; Lavigne P; Escher E; Leduc R
Biochem J; 2007 Feb; 402(1):51-61. PubMed ID: 17064254
[TBL] [Abstract][Full Text] [Related]
2. Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain.
Boucard AA; Sauvé SS; Guillemette G; Escher E; Leduc R
Biochem J; 2003 Mar; 370(Pt 3):829-38. PubMed ID: 12495432
[TBL] [Abstract][Full Text] [Related]
3. Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptor.
Holleran BJ; Domazet I; Beaulieu ME; Yan LP; Guillemette G; Lavigne P; Escher E; Leduc R
Biochem Pharmacol; 2009 Apr; 77(8):1374-82. PubMed ID: 19426676
[TBL] [Abstract][Full Text] [Related]
4. Ligand-supported purification of the urotensin-II receptor.
Du AT; Onan D; Dinh DT; Lew MJ; Ziogas J; Aguilar MI; Pattenden LK; Thomas WG
Mol Pharmacol; 2010 Oct; 78(4):639-47. PubMed ID: 20647393
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor.
Batuwangala M; Camarda V; McDonald J; Marzola E; Lambert DG; Ng LL; Calo' G; Regoli D; Trapella C; Guerrini R; Salvadori S
Peptides; 2009 Jun; 30(6):1130-6. PubMed ID: 19463746
[TBL] [Abstract][Full Text] [Related]
7. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of potent cystine-free cyclic hexapeptide agonists at the human urotensin receptor.
Foister S; Taylor LL; Feng JJ; Chen WL; Lin A; Cheng FC; Smith AB; Hirschmann R
Org Lett; 2006 Apr; 8(9):1799-802. PubMed ID: 16623554
[TBL] [Abstract][Full Text] [Related]
9. Identification of new agonists of urotensin-II from a cyclic peptide library.
Odagami T; Tsuda Y; Kogami Y; Kouji H; Okada Y
Bioorg Med Chem; 2009 Sep; 17(18):6742-7. PubMed ID: 19695883
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
[TBL] [Abstract][Full Text] [Related]
11. Urotensin-II receptor peptide agonists.
Carotenuto A; Grieco P; Novellino E; Rovero P
Med Res Rev; 2004 Sep; 24(5):577-88. PubMed ID: 15224381
[TBL] [Abstract][Full Text] [Related]
12. Identification of transmembrane domain 3, 4 & 5 residues that contribute to the formation of the ligand-binding pocket of the urotensin-II receptor.
Sainsily X; Cabana J; Boulais PE; Holleran BJ; Escher E; Lavigne P; Leduc R
Biochem Pharmacol; 2013 Dec; 86(11):1584-93. PubMed ID: 24084430
[TBL] [Abstract][Full Text] [Related]
13. Biological properties and functional determinants of the urotensin II receptor.
Proulx CD; Holleran BJ; Lavigne P; Escher E; Guillemette G; Leduc R
Peptides; 2008 May; 29(5):691-9. PubMed ID: 18155322
[TBL] [Abstract][Full Text] [Related]
14. Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II.
Boivin S; Ségalas-Milazzo I; Guilhaudis L; Oulyadi H; Fournier A; Davoust D
Peptides; 2008 May; 29(5):700-10. PubMed ID: 18423797
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11).
Marzola E; Camarda V; Batuwangala M; Lambert DG; Calo' G; Guerrini R; Trapella C; Regoli D; Tomatis R; Salvadori S
Peptides; 2008 May; 29(5):674-9. PubMed ID: 17822806
[TBL] [Abstract][Full Text] [Related]
16. Urotensin-II receptor ligands. From agonist to antagonist activity.
Grieco P; Carotenuto A; Campiglia P; Marinelli L; Lama T; Patacchini R; Santicioli P; Maggi CA; Rovero P; Novellino E
J Med Chem; 2005 Nov; 48(23):7290-7. PubMed ID: 16279788
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor.
Miller LJ; Dong M; Harikumar KG; Gao F
Biochem Soc Trans; 2007 Aug; 35(Pt 4):709-12. PubMed ID: 17635130
[TBL] [Abstract][Full Text] [Related]
18. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).
Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J
J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography.
Disa J; Floyd LE; Edwards RM; Douglas SA; Aiyar NV
Peptides; 2006 Jun; 27(6):1532-7. PubMed ID: 16290260
[TBL] [Abstract][Full Text] [Related]
20. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.
Elshourbagy NA; Douglas SA; Shabon U; Harrison S; Duddy G; Sechler JL; Ao Z; Maleeff BE; Naselsky D; Disa J; Aiyar NV
Br J Pharmacol; 2002 May; 136(1):9-22. PubMed ID: 11976263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
